Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $17.15 USD
Change Today +0.57 / 3.44%
Volume 754.0
As of 8:10 PM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

reed elsevier plc (RUKEF) Snapshot

Open
$17.15
Previous Close
$16.58
Day High
$17.15
Day Low
$17.15
52 Week High
02/25/15 - $18.48
52 Week Low
05/14/14 - $14.73
Market Cap
35.7B
Average Volume 10 Days
515.5
EPS TTM
--
Shares Outstanding
1.1B
EX-Date
04/30/15
P/E TM
--
Dividend
$30.07
Dividend Yield
2.65%
Current Stock Chart for REED ELSEVIER PLC (RUKEF)

Related News

No related news articles were found.

reed elsevier plc (RUKEF) Related Businessweek News

View More BusinessWeek News

reed elsevier plc (RUKEF) Details

Reed Elsevier PLC provides information solutions for professional customers in North America and Europe. The company’s Scientific, Technical & Medical segment publishes research, reference, and education content; and offers database and workflow solutions for scientists, academic institutions, educators, research leaders and administrators, medical researchers, doctors, nurses, and allied health professionals and students, as well as hospitals, research institutions, health insurers, managed healthcare organizations, research-intensive corporations, and governments. This segment also provides abstract and citation database of research literature; solutions for synthetic chemists; Web-based tools for the engineering community; a suite of products for academic and government research administrators, which helps to establish, execute, and evaluate research strategies. Its Risk & Business Information segment offers data and analytics to personal, commercial, and life insurance carriers, as well as to government and healthcare; risk and identity management, fraud detection, credit risk management, and compliance solutions for financial institutions, as well as for corporate customers in retail, telecommunications, and utilities sectors; and receivables management solutions. This segment also provides tracing, identity verification, fraud prevention, anti-money laundering, debt collection, and data cleansing solutions; risk-related information to the legal industry; information and online data services, and various other data services, as well as produces conferences, Websites, and business magazines. The company’s Legal segment offers legal, tax, regulatory, news and business information, and analysis services to legal, corporate, government, and academic customers. Its Exhibitions segment organizes exhibitions and conferences in various industries. The company was founded in 1894 and is based in London, the United Kingdom.

Founded in 1894

reed elsevier plc (RUKEF) Top Compensated Officers

Chief Executive Officer and Executive Directo...
Total Annual Compensation: 2.3M GBP
Chief Financial Officer and Executive Directo...
Total Annual Compensation: 902.0K GBP
Compensation as of Fiscal Year 2014.

reed elsevier plc (RUKEF) Key Developments

BioMed Realty Trust, Inc. Signs Reed Elsevier to Expand in Cambridge into 33,500 Square Feet in Company's 50 Hampshire Property

BioMed Realty Trust Inc. announced the signing of a new ten-year lease for approximately 33,500 square feet at 50 Hampshire with Reed Elsevier. The lease marks the first at the Cambridge property being vacated by CDM Smith Inc. at the end of March 2015. Later this year, Reed Elsevier will be taking the entire fifth floor of the over 180,000 square foot building in East Cambridge to relocate its current offices. The building will offer their employees on-site cafe and restaurants, new fitness center, open spaces for collaboration and meetings, and a new lobby to welcome the innovation community that the property serves. Beyond the amenities, 50 Hampshire offers employees flexible transportation options, with easy access to the T Red Line, on-site bike storage and parking within the building.

Reed Elsevier PLC, Annual General Meeting, Apr 23, 2015

Reed Elsevier PLC, Annual General Meeting, Apr 23, 2015. Agenda: To receive the 2014 annual report; to approve remuneration report; to consider declaration of 2014 final dividend; to consider re-appointment of auditors; to consider auditors' remuneration; to consider re-elect Erik Engstrom, Anthony Habgood, Wolfhart Hauser, Adrian Hennah, Lisa Hook, Nick , Robert Polet, Linda Sanford, Ben van der Veer as a directors; to consider authority to allot shares; to consider disapplication of pre-emption rights; to consider authority to purchase own shares; to consider notice period for general meetings; to consider approve Reed Elsevier NV resolutions; and to consider change of company name.

Reed Elsevier PLC Proposes 2014 Full Year Dividend; Reports Earnings Results for the Year Ended December 31, 2014

Reed Elsevier PLC proposed full year dividend up by 6% to 26.0 pence. The proposed average full year dividend growth rate is broadly in line with adjusted EPS growth at constant currency rates. The company full year dividends are covered 2.2x by adjusted EPS respectively. The company reported earnings results for the year ended December 31, 2014. For the year, the company reported revenue of GBP 5,773 million compared to GBP 6,035 million a year ago. Adjusted operating profit was GBP 1,739 million compared to GBP 1,749 million a year ago. Reported operating profit was GBP 1,402 million compared to GBP 1,376 million a year ago. Adjusted profit before tax was GBP 1,592 million compared to GBP 1,572 million a year ago. Adjusted net profit was GBP 1,213 million compared to GBP 1,197 million a year ago. Reported net profit was GBP 955 million compared to GBP 1,110 million a year ago. Adjusted earnings per share were 56.3 pence compared to 54.0 pence a year ago. Reported earnings per share were 43.0 pence compared to 48.8 pence a year ago. The improvement in profitability reflects a combination of underlying revenue growth, process innovation and portfolio development. Net debt was GBP 3.5 billion as on 31 December 2014. The tax rate on adjusted profit remained at 23.5%. In terms of cash flow, operating cash flow conversion was well over 90%. Legal CapEx remained at 10% of revenue as the company continue to roll out the new RELX platform. CapEx in STM was at lower than normal due to the projects. Cash interest payments were lower, reflecting lower borrowing costs and the timing of interest payments while cash were in line with accounting charge, giving free cash flow of GBP 1.15 billion, just ahead of 2013. CapEx was actually lower in 2014, but average spend is around GBP 300 million per annum, about 5% of revenue.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RUKEF:US $17.15 USD +0.57

RUKEF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RUKEF.
View Industry Companies
 

Industry Analysis

RUKEF

Industry Average

Valuation RUKEF Industry Range
Price/Earnings 25.3x
Price/Sales -- Not Meaningful
Price/Book 10.9x
Price/Cash Flow 24.7x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REED ELSEVIER PLC, please visit www.reedelsevier.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.